Physician profile
Jay Patel
NPI 1659786945
$47,936.45
in general payments reported to CMS, 2019-2025
26 companies · $1,295 in 2025
The $1,295 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,338 · 2020: $17K · 2021: $2,585 · 2022: $8,890 · 2023: $12K · 2024: $4,794 · 2025: $1,295.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Honoraria: $10K · Food and Beverage: $4,352 · Travel and Lodging: $3,538.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Honoraria | $10,340.00 |
| Food and Beverage | $4,351.65 |
| Travel and Lodging | $3,537.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Philips North America LLC | $18,335.50 | 2022-2023 | |
| Medtronic Vascular, INC. | $15,000.00 | 2020 | |
| Abiomed | $2,644.43 | 2019-2024 | Impella |
| Penumbra, INC. | $2,441.89 | 2021-2025 | Indigo System |
| Boston Scientific Corporation | $2,337.93 | 2019-2025 | Watchman Access System, Watchman Flx, Opticross |
| Inari Medical, INC. | $2,112.17 | 2023-2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Medtronic, INC. | $1,252.26 | 2021-2024 | Symplicity G3, Endurant Iis |
| Shockwave Medical, INC | $694.70 | 2021-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Abbott Laboratories | $658.58 | 2020-2025 | Navitor |
| Amgen INC. | $650.60 | 2021-2025 | Repatha, Repatha |
| Janssen Pharmaceuticals, INC | $456.00 | 2019-2024 | Xarelto |
| Thrombolex, INC. | $405.22 | 2025 | Bashir Endovascular Catheter |
| Teleflex LLC | $275.92 | 2019-2023 | Trapliner |
| Bayer Healthcare Pharmaceuticals INC. | $113.91 | 2025 | |
| Novartis Pharmaceuticals Corporation | $101.65 | 2024-2025 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $87.76 | 2021 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $81.92 | 2025 | Lifevest |
| Cordis US Corp. | $73.78 | 2022 | |
| Stryker Corporation | $52.42 | 2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Pfizer INC. | $36.32 | 2024 | |
| Alnylam Pharmaceuticals INC. | $26.17 | 2025 | Onpattro |
| Recor Medical INC | $22.32 | 2024 | Paradise Renal Denervation System |
| E.R. Squibb & Sons, L.L.C. | $21.01 | 2025 | Camzyos |
| Irhythm Technologies, INC. | $19.93 | 2023 | Zio Xt Patch |
| Kiniksa Pharmaceuticals International, Plc | $19.07 | 2024 | Arcalyst |
| Pharmacyclics LLC, An Abbvie Company | $14.99 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jay Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.